Teachers Advisors LLC boosted its position in Oxford Immunotec Global PLC (NASDAQ:OXFD) by 20.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 55,674 shares of the company’s stock after purchasing an additional 9,474 shares during the period. Teachers Advisors LLC owned about 0.24% of Oxford Immunotec Global PLC worth $936,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in OXFD. Nationwide Fund Advisors lifted its position in Oxford Immunotec Global PLC by 1.9% in the first quarter. Nationwide Fund Advisors now owns 13,765 shares of the company’s stock valued at $213,000 after purchasing an additional 254 shares during the period. American International Group Inc. lifted its position in Oxford Immunotec Global PLC by 7.1% in the first quarter. American International Group Inc. now owns 13,668 shares of the company’s stock valued at $212,000 after purchasing an additional 904 shares during the period. Renaissance Technologies LLC lifted its position in Oxford Immunotec Global PLC by 97.8% in the first quarter. Renaissance Technologies LLC now owns 363,300 shares of the company’s stock valued at $5,628,000 after purchasing an additional 179,600 shares during the period. Goldman Sachs Group Inc. lifted its position in Oxford Immunotec Global PLC by 175.0% in the first quarter. Goldman Sachs Group Inc. now owns 35,678 shares of the company’s stock valued at $553,000 after purchasing an additional 22,704 shares during the period. Finally, Parkwood LLC lifted its position in Oxford Immunotec Global PLC by 12.9% in the second quarter. Parkwood LLC now owns 12,799 shares of the company’s stock valued at $215,000 after purchasing an additional 1,465 shares during the period. Hedge funds and other institutional investors own 79.21% of the company’s stock.

A number of equities research analysts recently commented on the stock. Piper Jaffray Companies reduced their price objective on shares of Oxford Immunotec Global PLC from $26.00 to $19.00 and set an “overweight” rating for the company in a research report on Tuesday. Zacks Investment Research downgraded shares of Oxford Immunotec Global PLC from a “hold” rating to a “sell” rating in a research report on Wednesday, August 30th. Robert W. Baird reiterated a “buy” rating and set a $20.00 price target on shares of Oxford Immunotec Global PLC in a research report on Wednesday. BTIG Research set a $21.00 price target on shares of Oxford Immunotec Global PLC and gave the company a “buy” rating in a research report on Tuesday. Finally, ValuEngine downgraded shares of Oxford Immunotec Global PLC from a “hold” rating to a “sell” rating in a research report on Tuesday. Three equities research analysts have rated the stock with a sell rating and four have issued a buy rating to the company’s stock. Oxford Immunotec Global PLC presently has a consensus rating of “Hold” and a consensus price target of $19.75.

Shares of Oxford Immunotec Global PLC (OXFD) opened at $13.25 on Friday. The company has a quick ratio of 2.51, a current ratio of 4.72 and a debt-to-equity ratio of 0.38.

Oxford Immunotec Global PLC (NASDAQ:OXFD) last announced its quarterly earnings results on Tuesday, August 1st. The company reported ($0.32) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.32). Oxford Immunotec Global PLC had a negative return on equity of 38.42% and a negative net margin of 45.74%. The business had revenue of $26.10 million for the quarter, compared to the consensus estimate of $25.05 million. During the same period last year, the business posted ($0.29) EPS. The business’s revenue was up 35.9% compared to the same quarter last year. research analysts forecast that Oxford Immunotec Global PLC will post -2.11 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/oxford-immunotec-global-plc-oxfd-position-raised-by-teachers-advisors-llc/1677356.html.

In other news, Director Richard A. Sandberg sold 3,000 shares of Oxford Immunotec Global PLC stock in a transaction on Friday, September 1st. The stock was sold at an average price of $15.82, for a total value of $47,460.00. Following the transaction, the director now directly owns 18,000 shares in the company, valued at approximately $284,760. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Peter Edwardson sold 22,371 shares of Oxford Immunotec Global PLC stock in a transaction on Monday, August 7th. The shares were sold at an average price of $17.70, for a total value of $395,966.70. Following the completion of the transaction, the chief operating officer now owns 102,644 shares in the company, valued at $1,816,798.80. The disclosure for this sale can be found here. Insiders sold a total of 93,110 shares of company stock worth $1,563,564 over the last quarter. Company insiders own 8.11% of the company’s stock.

Oxford Immunotec Global PLC Profile

Oxford Immunotec Global PLC is a diagnostics company. The Company is focused on developing and commercializing tests for under-served immune-regulated conditions. The Company’s product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology.

Want to see what other hedge funds are holding OXFD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oxford Immunotec Global PLC (NASDAQ:OXFD).

Institutional Ownership by Quarter for Oxford Immunotec Global PLC (NASDAQ:OXFD)

Receive News & Ratings for Oxford Immunotec Global PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Immunotec Global PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.